Skip to main content

Table 1 Clinical features of patients with bone and soft tissue sarcoma in AYA

From: Surgical management of sarcoma in adolescent and young adult patients

Patient no.

Age

Bone or soft tissue

Site

Histology

Grade

ECOG-PS

ASA-PS

Chemotherapy

Treatment

Op. time (min)

Blood loss (mL)

Margin

Local recurrence

Metastasis

Follow-up period

Final outcome

1

17

Bone

Tibia

Osteosarcoma (conventional)

High

1

1

NECO-95J

CT, WR

160

500

R1

+

+

43

DOD

2

36

Bone

Tibia

Osteosarcoma (conventional)

High

0

1

NECO-95J

Curettage

108

10

+

55

NED

3

39

Bone

Femur

Chondrosarcoma grade I

Low

0

1

Curettage

240

860

66

CDF

4

33

Bone

Femur

Chondrosarcoma grade II

Low

0

1

Curettage

120

160

75

CDF

5

15

Bone

Femur

Osteosarcoma (osteoblastic)

High

2

1

NECO-95J

CT, WR

215

521

R0

88

CDF

6

36

Bone

Tibia

Osteosarcoma (chondroblastic)

High

0

1

NECO-95J

CT, WR

245

250

R0

43

CDF

7

27

Bone

Fibula

Osteosarcoma (conventional)

High

0

1

NECO-95J

CT, WR

500

392

R0

162

CDF

8

29

Bone

Humerus

Osteosarcoma (conventional)

High

1

2

NECO-95J

CT, WR

295

571

R0

+

12

DOD

9

35

Soft tissue

Thigh

Leiomyosarcoma

High

1

3

WR

245

418

R0

+

45

DOD

10

32

Soft tissue

Buttock

Ewing

High

1

2

VAdCA-IE

CT, WR

140

615

R0

+

13

DOD

11

35

Soft tissue

Thigh

Synovial sarcoma

High

0

1

IA × 3 (post surgery)

CT, WR

364

282

R1

+

20

NED

12

27

Soft tissue

Abdomen

Synovial sarcoma

High

0

1

IA × 3 (post surgery)

CT, WR

102

10

R0

40

CDF

13

36

Soft tissue

Upper extremity

Liposarcoma

High

1

1

WR

95

10

R0

+

54

DOD

14

26

Soft tissue

Thigh

Myxoid liposarcoma

Low

0

1

WR

140

935

R0

144

CDF

15

34

Soft tissue

Thigh

Myxoid liposarcoma

High

0

1

IA 3 (pre-surgery)/2 (Post surgery)

CT, WR

145

138

R1

+

111

NED

16

33

Soft tissue

Thigh

Synovial sarcoma

High

0

1

IA 3 (pre-surgery)/2 (post surgery)

CT, WR

237

235

R0

36

CDF

17

37

Soft tissue

Buttock

Myxoid liposarcoma

High

0

1

IA × 3 (post surgery)

CT, WR

103

196

R0

8

CDF

18

32

Soft tissue

Groin

Myxoid liposarcoma

High

0

1

IA × 3 (post surgery)

WR, RT

191

50

R0

10

CDF

  1. y years, F female, M male, CT chemotherapy, WR wide resection, NECO Neoadjuvant Chemotherapy for Osteosarcoma, IA ifosfamide and doxorubicin, Mo month(s), DOD dead of disease, CDF continuously disease-free, ECOG-PS European Society for Medical Oncology Guidelines Performance Status, ASA-PS American Society of Anesthesiologists-Physical Status, Op. time operation time, VAdCA-IE vincristin, actinomycinD, doxorubicin, cyclophosphamide, ifosfamide, etoposide, NED no evidence of disease